Display options
Cite
Kim YM. Improving the lives of children with neurofibromatosis type 1. Clin Exp Pediatr. 2020;64(4):165-166doi: 10.3345/cep.2020.01277.
Kim, Y. M. (2021). Improving the lives of children with neurofibromatosis type 1. Clinical and experimental pediatrics, 64(4), 165-166. https://doi.org/10.3345/cep.2020.01277
Kim, Yoo-Mi. "Improving the lives of children with neurofibromatosis type 1." Clinical and experimental pediatrics vol. 64,4 (2021): 165-166. doi: https://doi.org/10.3345/cep.2020.01277
Kim YM. Improving the lives of children with neurofibromatosis type 1. Clin Exp Pediatr. 2021 Apr;64(4):165-166. doi: 10.3345/cep.2020.01277. Epub 2020 Sep 18. PMID: 32972053; PMCID: PMC8024116.
Copy Download .nbib Format: NLM
Share it on

Clin Exp Pediatr. 2021 Apr;64(4):165-166. doi: 10.3345/cep.2020.01277. Epub 2020 Sep 18.

Improving the lives of children with neurofibromatosis type 1.

Clinical and experimental pediatrics

Yoo-Mi Kim

Affiliations

  1. Department of Pediatrics, Chungnam National University, College of Medicine, Chungnam National University Sejong Hospital, Sejong, Korea.

PMID: 32972053 PMCID: PMC8024116 DOI: 10.3345/cep.2020.01277

[No abstract available.]

References

  1. Lancet Child Adolesc Health. 2020 Jul;4(7):488-490 - PubMed
  2. N Engl J Med. 2020 Apr 9;382(15):1430-1442 - PubMed
  3. Clin Exp Pediatr. 2021 Apr;64(4):149-156 - PubMed
  4. Br J Cancer. 2018 Jun;118(12):1539-1548 - PubMed
  5. Nat Rev Clin Oncol. 2020 May;17(5):273 - PubMed
  6. J Child Neurol. 2002 Aug;17(8):562-70; discussion 571-2, 646-51 - PubMed
  7. Med Clin North Am. 2019 Nov;103(6):1035-1054 - PubMed
  8. J Med Genet. 2007 Feb;44(2):81-8 - PubMed
  9. Pediatrics. 2019 May;143(5): - PubMed
  10. J Biomed Sci. 2018 Oct 5;25(1):72 - PubMed

Publication Types